JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
AURX Financials - Nuo Therapeutics Income & Cash Flow | Ledgeburg
AURX - Nuo Therapeutics, Inc.
USD | OTC Markets | Healthcare
Summary
Summary AURX Stock
Financials
Financials AURX Stock
Loading...
Loading...
Income Statement
Income Statement AURX Stock
Balance Sheet
Balance Sheet AURX Stock
Cash Flow Statement
Cash Flow Statement AURX Stock
Loading...
Loading...
Home
Stocks
Nuo Therapeutics, Inc. (AURX)
Financials
Financials of AURX
Loading...
Loading...
Loading...
Loading...
Revenue
$3.313509M
Operating Income
$-2.516649M
Net Income
$-2.512216M
Share Count (Basic)
47.312727M
Operating Cash Flow
$-864.971K
Free Cash Flow
$-1.139727M
Cash And Short-Term Equivalents
$548.946K
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
1M
2M
3M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
500K
1M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-3M
-2M
-1M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-750K
-700K
-650K
-600K
-550K
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-150%
-100%
-50%
0%
50%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26